Equities researchers at Zacks Research lifted their FY2025 earnings per share estimates for shares of Bruker in a research ...

Bruker Co. (NASDAQ:BRKR – Get Free Report) has received a consensus rating of “Moderate Buy” from the eleven analysts that are presently covering the company, Marketbeat Ratings reports. Five research ...

Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels.

Bruker Corporation BRKR recently launched the new X4 POSEIDON, a high-performance 3D X-ray microscope (XRM) using ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

The X4 POSEIDON is designed for use in industrial applications and scientific research. Since the announcement on Feb. 27, shares of Bruker have lost 7.2%, finishing at $46.87 yesterday.

Headlines,Bruker Corporation,(NASDAQ:BRKR),specializes in scientific instruments and diagnostic solutions.,The stock experienced a one-month return of -9.12% and a year-over-year decrease of ...

Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels.